CN104274444A - 达比加群酯或其盐的口服双微丸药物组合物 - Google Patents
达比加群酯或其盐的口服双微丸药物组合物 Download PDFInfo
- Publication number
- CN104274444A CN104274444A CN201310280978.3A CN201310280978A CN104274444A CN 104274444 A CN104274444 A CN 104274444A CN 201310280978 A CN201310280978 A CN 201310280978A CN 104274444 A CN104274444 A CN 104274444A
- Authority
- CN
- China
- Prior art keywords
- micropill
- pharmaceutical composition
- acid
- organic acid
- tartaric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310280978.3A CN104274444B (zh) | 2013-07-04 | 2013-07-04 | 达比加群酯或其盐的口服双微丸药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310280978.3A CN104274444B (zh) | 2013-07-04 | 2013-07-04 | 达比加群酯或其盐的口服双微丸药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104274444A true CN104274444A (zh) | 2015-01-14 |
CN104274444B CN104274444B (zh) | 2018-07-24 |
Family
ID=52250108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310280978.3A Active CN104274444B (zh) | 2013-07-04 | 2013-07-04 | 达比加群酯或其盐的口服双微丸药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104274444B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108261409A (zh) * | 2017-01-02 | 2018-07-10 | 齐鲁制药有限公司 | 一种达比加群酯的口服药物组合物及其制备方法 |
CN113332256A (zh) * | 2021-05-21 | 2021-09-03 | 江苏宇锐医药科技有限公司 | 一种达比加群酯微丸组合胶囊及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574328A (zh) * | 2009-06-18 | 2009-11-11 | 中国药科大学 | 一种唑吡坦盐的择时脉冲释药微丸 |
WO2011082426A1 (en) * | 2010-01-04 | 2011-07-07 | Eurand, Inc. | Controlled release compositions comprising meclizine or related piperazine derivatives |
CN102657615A (zh) * | 2012-05-02 | 2012-09-12 | 上海智同医药科技有限公司 | 一种长春胺缓释微丸制剂及其制备方法 |
CN103127109A (zh) * | 2013-02-05 | 2013-06-05 | 南京华威医药科技开发有限公司 | 含达比加群酯或其盐和水合物的药用组合 |
-
2013
- 2013-07-04 CN CN201310280978.3A patent/CN104274444B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574328A (zh) * | 2009-06-18 | 2009-11-11 | 中国药科大学 | 一种唑吡坦盐的择时脉冲释药微丸 |
WO2011082426A1 (en) * | 2010-01-04 | 2011-07-07 | Eurand, Inc. | Controlled release compositions comprising meclizine or related piperazine derivatives |
CN102657615A (zh) * | 2012-05-02 | 2012-09-12 | 上海智同医药科技有限公司 | 一种长春胺缓释微丸制剂及其制备方法 |
CN103127109A (zh) * | 2013-02-05 | 2013-06-05 | 南京华威医药科技开发有限公司 | 含达比加群酯或其盐和水合物的药用组合 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108261409A (zh) * | 2017-01-02 | 2018-07-10 | 齐鲁制药有限公司 | 一种达比加群酯的口服药物组合物及其制备方法 |
CN113332256A (zh) * | 2021-05-21 | 2021-09-03 | 江苏宇锐医药科技有限公司 | 一种达比加群酯微丸组合胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104274444B (zh) | 2018-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100352432C (zh) | 含有那格列奈的制剂 | |
CN1886119B (zh) | 泮托拉唑多颗粒制剂 | |
JP4260370B2 (ja) | 塩酸ファスジルの経口徐放性製剤 | |
CN101987091B (zh) | 盐酸文拉法辛缓释微丸胶囊 | |
CN106102716A (zh) | 雄激素受体拮抗剂的固体药物组合物 | |
WO2018108152A1 (zh) | 一种奥拉帕尼口服缓控释药物组合物及其用途 | |
JP2010163464A (ja) | β−カルボリン製薬組成物 | |
WO2011063732A1 (zh) | 一种帕利哌酮双层渗透泵控释片及其制备方法 | |
WO2022012172A1 (zh) | 一种难溶性药物口服缓释组合物及其制备方法 | |
CN111012756B (zh) | 一种达比加群酯药物组合物及其制备方法 | |
CN103565770A (zh) | 一种右兰索拉唑肠溶缓控释微丸片 | |
CN104414978A (zh) | 一种含有埃索美拉唑镁的肠溶微丸 | |
KR20080076440A (ko) | 실로스타졸의 제어방출 제제 및 그 제조방법 | |
CN110062628A (zh) | 一种瑞卡帕布口服缓控释药物组合物及其用途 | |
CN100475197C (zh) | 口服的可持续释放的药用组合物 | |
Foppoli et al. | Evaluation of powder-layering vs. spray-coating techniques in the manufacturing of a swellable/erodible pulsatile delivery system | |
CN109789102A (zh) | 包含埃索美拉唑或其药学上可接受的盐的具有改善pH依赖性药物释放特性的制剂 | |
CN103142492A (zh) | 一种缓释微丸制剂及其制备方法 | |
CN102716090A (zh) | 一种盐酸二甲双胍缓释微丸及其制备方法 | |
EP2359814A1 (en) | Pharmaceutical mini-tablets for sustained release of flecainide acetate | |
WO2012020301A2 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
CN103717209A (zh) | 速释的含普拉格雷的稳定的口服药物组合物 | |
CN104274444B (zh) | 达比加群酯或其盐的口服双微丸药物组合物 | |
US9498440B2 (en) | Extended release pharmaceutical compositions | |
CN105055350A (zh) | 一种含有质子泵抑制剂的片剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160324 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |